MAAT PHARMA revenue breakdown overview

MAAT PHARMA revenue for the last year amounted to 3.22 M EUR, the most of which — 3.22 M EUR — came from its highest performing source at the moment, Microbiome Ecosystem Therapies, the year earlier bringing 2.23 M EUR. The greatest contribution to the revenue figure was made by France — last year it brought MAAT PHARMA 3.22 M EUR, and the year before that — 2.23 M EUR.